Citation: | Fang Shichang. Twenty Four Patients with Hepatic Metastases fromColorectal Cancer Treated by Resection:Clinical Analysis[J]. Cancer Research on Prevention and Treatment, 1997, 24(3): 172-173. |
1. Bradpiece HA,et al.Major heaptic rsection for color-ectal liver metastasese.Br J Surg,1987,74(4),324.
|
2. 李庆怀,刘声明.大肠癌肝转移治疗进展.中国肿瘤临 床杂志,1990,17(3),176.
|
3. 汤钊酞.现代肿瘤学.第1版.上海:上海医科大学出 版社,1993,536.
|
4. 彭淑篇,等.刮吸法断肝术临床应用报告.实用外科杂 志,1993,13(1):18.
|
5. Thomas A,Nims MD.Resection of the fiver for me-tastatic cancer.SGO,1984,158:46.
|
6. Yaman Fong MD,et al.Surgical treatment of colorec-tal metastases to the liver.Cancer Clin,1985,45(1): 50.
|
7. Talor 1 Colorectal liver metastases-to tr-eat or not treat Br J Surg,1985.72(7),511.
|
8. Ekberg Heterminants of survival in liver re-section for colorectal secondaries.Br.J.Surg.1986,73(9):727.
|
9. Joseph,G.Fontner Recurrence of colorectal cancer af-ter hepatic resection.Am J Surg.1988,1JJ(3),378.
|
10 Jemes.H.Foster,MD Survival rate of operation for secondary liver metastases.Am J Surg,1978.135,389.
|
11 Huges K.Resection of the liver for colorectal carcino-ma metastases; A multistitutional study of the pat-terns of recurrence.Surgery,1986,100(2),278.
|
[1] | REN Jianwei, ZHOU Zubang, MA Wenjuan, YANG Daxiong, REN Yiqun, ZHANG Zhi, NIU Yanqiang, CAO Lei. Expression of PD-L1 in Primary Colorectal Cancer and Its Predictive Value for Recurrence After Microwave Ablation of Liver Metastases[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 38-42. DOI: 10.3971/j.issn.1000-8578.2023.22.0538 |
[2] | ZHOU Sicheng, WU Haifeng, PAN Yuting, YUN Hong, CAO Shaomu, NIE Hongxia, XING Wei, LIANG Jianwei. Clinicopathological Characteristics and Survival Prognosis Analysis of 102 Rectal Cancer Patients with Lateral Pelvic Lymph Node Metastases[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 33-37. DOI: 10.3971/j.issn.1000-8578.2023.22.0655 |
[3] | ZHAO Zhengqiang, CHEN Long, LIU Yujie, TIAN Suqing. Prognosis-related Factors of Colorectal Cancer Patients with Positive PD-L1 Expression in Liver Metastases After Hepatectomy[J]. Cancer Research on Prevention and Treatment, 2021, 48(8): 782-787. DOI: 10.3971/j.issn.1000-8578.2021.21.0124 |
[4] | KUANG Yuhui, CHEN Xinju, XU Fangbiao. Meta-analysis of Efficacy and Safety of Jinlong Capsule Combined with Chemoradiotherapy on Liver Metastases[J]. Cancer Research on Prevention and Treatment, 2020, 47(1): 63-69. DOI: 10.3971/j.issn.1000-8578.2020.19.0619 |
[5] | LI Zechao, ZHOU Yong, LUO Shiqiao. Clinical Analysis of Multimodality Treatments for Pancreatic Cancer Patients with Liver Metastases[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 154-158. DOI: 10.3971/j.issn.1000-8578.2015.02.012 |
[6] | REN Qing, XIONG Ruihua, TIAN Xiurong, BAO Zhongping, TANG Xinyun, LUO Kepin. 125I Seed Implantation Combined with Chemotherapy for Colorectal Cancer with Postoperative Liver Metastasis[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 653-656. DOI: 10.3971/j.issn.1000-8578.2014.06.032 |
[7] | HAN Guang, XIAO Chuangying, WANG Zhaohua, NIE Lei, WANG Mingwei, GUO Xiaofang, WU Yuan. Role of Surgery for Limited Liver Metastases from Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(11): 1079-1083. DOI: 10.3971/j.issn.1000-8578.2013.11.015 |
[8] | YANG Chunkang, HUANG Xiaorong, YING Mingang. Effects of SDF-1 and CXCR4 on HPA Expression in Liver Metastases Induced by Colorectal Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2013, 40(09): 839-839. DOI: 10.3971/j.issn.1000-8578.2013.09.005 |
[9] | ZHNAG Yong-gang. Relative Histopathologic Evaluation of Colorectal Cancer with Liver Metastasis[J]. Cancer Research on Prevention and Treatment, 2004, 31(10): 655-656. DOI: 10.3971/j.issn.1000-8578.2093 |
[10] | NIU Xiao-min, ZHANG Xiao-peng. CT Diagnosis of Hepatic Metastases in Fatty Liver[J]. Cancer Research on Prevention and Treatment, 2004, 31(10): 604-607. DOI: 10.3971/j.issn.1000-8578.2570 |